Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting

PURPOSE: To assess the levels of quality of life (QoL) in major depressive disorder (MDD) patients treated with either duloxetine or a selective serotonin reuptake inhibitor (SSRI) as monotherapy for up to 6 months in a naturalistic clinical setting mostly in the Middle East, East Asia, and Mexico....

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jihyung, Novick, Diego, Montgomery, William, Moneta, Maria Victoria, Dueñas, Héctor, Peng, Xiaomei, Haro, Josep Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621215/
https://www.ncbi.nlm.nih.gov/pubmed/26527865
http://dx.doi.org/10.2147/PPA.S89870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621215/
https://www.ncbi.nlm.nih.gov/pubmed/26527865
http://dx.doi.org/10.2147/PPA.S89870

Ejemplares similares